Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group
Quality functions from pharmaceutical sponsor companies aim to increase the use of analytics in their oversight of Good Clinical Practices and Pharmacovigilance activities. To leverage and accelerate progress, several companies decided to establish a collaborative model. The goals of this collaborat...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4f25ca3e1e574d46be9aacf06152718e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|